Smaller Doses of Monkeypox Vaccine Elicits Equal Immune Response in People Living With, Without HIV
January 3rd 2024The study results also determined that those who were previously vaccinated against smallpox had a 2.7 times higher immune response than those who were not previously vaccinated.
Read More
Expert: The Evolution of HIV Care, Treatment Options, How Pharmacists Can Assist in Providing Care
December 18th 2023Using information from clinical studies and her experiences working in the field, Stephanie Kirk describes treatment options that are on the horizon, and how removing stigma is key in HIV care.
Read More
PrEPVacc HIV Vaccine Trial Halted Due to Potential Inefficacy, But Oral PrEP Regimens Continue
December 18th 2023The study, which consists of 3 trials, will continue with oral PrEP regimens; however, the vaccination trials have stopped due to the unlikely chance of the vaccine showing efficacy.
Read More
Study Results Find Different Mechanisms of Action in 2 Immune Checkpoint Inhibitor Regimens
December 18th 2023The differences between the regimens, anti-PD1/CTLA-4 and anti-PD1/LAG-3, can be used to optimize outcomes for patients with melanoma, particularly in those who develop drug resistance.
Read More
Disparities Across European NEAT ID Centers Impact Implementation, Roll-Out of PrEP
December 13th 2023Both individual and structural barriers were the most common hindrances to PrEP roll-out, and the investigators emphasize that efforts to remove the obstacles as well as further research can help improve PrEP implementation.
Read More
No Significant Differences at 5 Year Follow-Up Between Palbociclib-Based Treatment Regimens
December 8th 2023Study results indicate insignificant differences between PFS and OS in patients with HR[+]/HER2[-] breast cancer who received either palbociclib-letrozole or palbociclib-fulvestrant treatment.
Read More